Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 3
1954 11
1955 10
1956 8
1957 6
1958 2
1959 3
1960 2
1962 1
1963 1
1964 3
1965 11
1966 19
1967 13
1968 9
1969 13
1970 16
1971 16
1972 10
1973 18
1974 16
1975 16
1976 29
1977 26
1978 16
1979 16
1980 24
1981 25
1982 14
1983 20
1984 27
1985 21
1986 25
1987 25
1988 37
1989 39
1990 75
1991 62
1992 60
1993 70
1994 50
1995 46
1996 51
1997 52
1998 59
1999 53
2000 57
2001 60
2002 60
2003 60
2004 57
2005 49
2006 78
2007 60
2008 57
2009 53
2010 51
2011 73
2012 79
2013 69
2014 72
2015 65
2016 67
2017 94
2018 93
2019 103
2020 104
2021 129
2022 95
2023 102
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

2,771 results

Results by year

Filters applied: . Clear all
Page 1
Pyridostigmine-induced microcephaly.
Polizzi A, Ruggieri M, Vincent A. Polizzi A, et al. Neurology. 2001 Jun 12;56(11):1606-7. Neurology. 2001. PMID: 11409415 No abstract available.
Pyridostigmine in chronic intestinal pseudo-obstruction - a systematic review.
Wilkie BD, Noori J, Johnston M, Woods R, Keck JO, Behrenbruch C. Wilkie BD, et al. ANZ J Surg. 2023 Sep;93(9):2086-2091. doi: 10.1111/ans.18478. Epub 2023 May 2. ANZ J Surg. 2023. PMID: 37132128 Review.
All studies reported improved patient outcomes with use of pyridostigmine, and low rates (4.3%) of mild cholinergic side effects. ...Further high-quality studies are required to enable assessment of pyridostigmine's utility as an effective management strategy in CIP …
All studies reported improved patient outcomes with use of pyridostigmine, and low rates (4.3%) of mild cholinergic side effects. ... …
Management of myasthenia gravis during pregnancy.
Bansal R, Goyal MK, Modi M. Bansal R, et al. Indian J Pharmacol. 2018 Nov-Dec;50(6):302-308. doi: 10.4103/ijp.IJP_452_17. Indian J Pharmacol. 2018. PMID: 30783322 Free PMC article. Review.
Pyridostigmine in the treatment of orthostatic intolerance.
Gales BJ, Gales MA. Gales BJ, et al. Ann Pharmacother. 2007 Feb;41(2):314-8. doi: 10.1345/aph.1H458. Epub 2007 Feb 6. Ann Pharmacother. 2007. PMID: 17284509 Review.
Long-term data consist of a single survey of patients receiving open-label pyridostigmine bromide. Twenty-nine percent of patients who initiated maintenance pyridostigmine bromide discontinued therapy. ...Pyridostigmine bromide significan …
Long-term data consist of a single survey of patients receiving open-label pyridostigmine bromide. Twenty-nine percent of pati …
Pyridostigmine-induced microcephaly.
Al-Shekhlee A, Robin N, Kaminski HJ. Al-Shekhlee A, et al. Neurology. 2001 Jun 12;56(11):1606-7. Neurology. 2001. PMID: 11402134 No abstract available.
Neurovascular Dysregulation and Acute Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Placebo-Controlled Trial of Pyridostigmine.
Joseph P, Pari R, Miller S, Warren A, Stovall MC, Squires J, Chang CJ, Xiao W, Waxman AB, Systrom DM. Joseph P, et al. Chest. 2022 Nov;162(5):1116-1126. doi: 10.1016/j.chest.2022.04.146. Epub 2022 May 6. Chest. 2022. PMID: 35526605 Clinical Trial.

RESULTS: Twenty-three subjects were assigned to receive pyridostigmine and 22 to receive placebo. The peak Vo(2) increased after pyridostigmine but decreased after placebo (13.3 13.4 mL/min vs -40.2 21.3 mL/min; P < .05). ...INTERPRETATION: Pyridostigmine

RESULTS: Twenty-three subjects were assigned to receive pyridostigmine and 22 to receive placebo. The peak Vo(2) increased after p
Pyridostigmine-induced microcephaly.
Niesen CE, Shah NS. Niesen CE, et al. Neurology. 2000 May 9;54(9):1873-4. doi: 10.1212/wnl.54.9.1873. Neurology. 2000. PMID: 10802806 No abstract available.
A woman from Kenosha.
Gutmann L. Gutmann L. Neurology. 2017 Jan 10;88(2):214-215. doi: 10.1212/WNL.0000000000003476. Neurology. 2017. PMID: 28069973 No abstract available.
Reversal of neuromuscular blockade.
Bevan DR, Donati F, Kopman AF. Bevan DR, et al. Anesthesiology. 1992 Oct;77(4):785-805. doi: 10.1097/00000542-199210000-00025. Anesthesiology. 1992. PMID: 1416176 Free article. Review. No abstract available.
Less stress--more pressure?
Fishman RA. Fishman RA. Nat Med. 1997 Apr;3(4):366. doi: 10.1038/nm0497-366a. Nat Med. 1997. PMID: 9095157 No abstract available.
2,771 results